Abstract:
본 발명은 땅꽈리( Physalis angulata L.) 추출물을 포함하는 혈관내피세포 노화로 유발되는 질병의 예방 또는 치료용 약학적 조성물에 관한 것으로, 본 발명의 땅꽈리 열매 추출물을 포함하는 혈관내피세포 노화로 유발되는 질병의 예방 또는 치료용 약학적 조성물은 효과적으로 섬유아세포 또는 혈관내피 세포 증식을 향상시키고 SA-β-갈락토시다아제 활성 저해를 통한 혈관내피 세포 노화를 억제할 수 있으므로, 심혈관질환, 만성신장질환, 만성염증성 피부질환, 아테롬성 염증 및 파킨슨병 등과 같은 혈관내피세포 노화로 유발되는 질환의 예방에 유용하게 사용될 수 있다.
Abstract:
The present invention relates to a composition comprising a Synurus deltoides (Aiton) Nakai extract for inhibiting cell aging. The composition, comprising the Synurus deltoides (Aiton) Nakai extract having an excellent effect of inhibiting cell aging as an active ingredient, can be used for preventing age-related diseases, such as skin aging, rheumatoid arthritis, osteoarthritis, hepatitis, chronic damage to skin tissues, arteriosclerosis, prostatic hyperplasia, or liver cancer.
Abstract:
A skin whitening composition is provided to suppress tyrosinase activation and melanogenesis using a Physalis alkekengi var. francheti extract. A pharmaceutical composition for skin whitening comprises a Physalis alkekengi var. francheti as an active ingredient. A solvent for extracting is selected among water, ethanol, methanol, propanol, butanol, acetone, ethylacetate, hexane, butyleneglycol, propyleneglycol, hydrous butyleneglycol, hydrous propyleneglycol, and hydrous glycerin. The pharmaceutical composition is used in a form of cream, gel, patch, spray, ointment, lotion, liniment, paste, or cataplasma. A cosmetic composition is used in a form of skin, lotion, nutrition lotion, nutrition cream, massage cream, essence, or pack.
Abstract:
PURPOSE: A cosmetic composition containing Aster ageratoides Turcz. var. ageratoides extract is provided to suppress tyrosinase and melanogenesis. CONSTITUTION: A cosmetic composition for whitening contains Aster ageratoides Turcz. var. ageratoides extract as an active ingredient. The Aster ageratoides Turcz. var. ageratoides extract is obtained by isolating petals, branches, stems, leaves, immature fruits, fruits using water, low alcohol of 1-4 carbon atoms, propylene glycol, acetic ethyl, butylenes glycol, ether, or chloroform. The cosmetic composition contains 0.001-90 weight% of Aster ageratoides Turcz. var. ageratoides extract.
Abstract:
PURPOSE: A composition for oral administration containing Aster ageratoides Turcz. var. ageratoides extract is provided to suppress tyrosinase and melanogenesis. CONSTITUTION: A composition for oral administration with whitening effect contains Aster ageratoides Turcz. var. ageratoides extract as an active ingredient. The Aster ageratoides Turcz. var. ageratoides is isolated from petal, branch, stem, leaf, immature fruit and fruit using water, low alcohol of 1-4 carbon atoms, propylene glycol, ethyl acetate, butylenes glycol, ether or chloroform at 10-100°C for 1 hour to 4 days.
Abstract:
PURPOSE: A composition containing Hypericum ascyron L. extract for preventing and treating bone diseases is provided to suppress bone absorption and to promote alkaline phosphatase and osteocalcin expression. CONSTITUTION: A composition for preventing or treating bone disease contains Hypericum ascyron L. extract as an active ingredient. The Hypericum ascyron L. extract is obtained using water, methanol, or mixture thereof. The composition suppresses formation of osteoclast. A pharmaceutical composition for preventing or treating bone diseases contains therapeutically effective amount of Hypericum ascyron L. extract and phamaceuitcally acceptable carrier.